On July 3, 2020, Anchiano Therapeutics Ltd, Chief Executive Officer Dr. Frank Haluska sent a letter to Chairman that the Board has considered and construes as notice of constructive resignation.   The letter outlined Dr. Haluska's belief that events have occurred that are sufficient to trigger his ability to resign for "Good Reason" under his employment agreement, and that he intends to resign as of August 8, 2020 assuming the "Good Reason" events are not cured within thirty (30) days. In the letter, Dr. Haluska also confirms his intent to resign as a director of the Company.